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Abstract
Neural stem cells (NSC) with self-renewal and multipotent properties serve as an ideal cell source for transplantation to treat
neurodegenerative insults such as Parkinson’s disease. We used Agilent’s and Illumina Whole Human Genome
Oligonucleotide Microarray to compare the genomic profiles of human embryonic NSC at a single time point in culture,
and a multicellular tissue from postmortem adult substantia nigra (SN) which are rich in dopaminergic (DA) neurons. We
identified 13525 up-regulated genes in both cell types of which 3737 (27.6%) genes were up-regulated in the hENSC, 4116
(30.4%) genes were up-regulated in the human substantia nigra dopaminergic cells, and 5672 (41.93%) were significantly
up-regulated in both cell population. Careful analysis of the data that emerged using DAVID has permitted us to distinguish
several genes and pathways that are involved in dopaminergic (DA) differentiation, and to identify the crucial signaling
pathways that direct the process of differentiation. The set of genes expressed more highly at hENSC is enriched in
molecules known or predicted to be involved in the M phase of the mitotic cell cycle. On the other hand, the genes
enriched in SN cells include a different set of functional categories, namely synaptic transmission, central nervous system
development, structural constituents of the myelin sheath, the internode region of axons, myelination, cell projection, cell
somata, ion transport, and the voltage-gated ion channel complex. Our results were also compared with data from various
databases, and between different types of arrays, Agilent versus Illumina. This approach has allowed us to confirm the
consistency of our obtained results for a large number of genes that delineate the phenotypical differences of embryonic
NSCs, and SN cells.
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Introduction
The adult CNS has a limited capacity to regenerate new
neurons, particularly in the substantia nigra, spinal cord, and
cortex [1]. In contrast, glial cells can be regenerated in low
numbers throughout the adult life span and the numbers
generated increase substantially after injury [2]. The embryonic
human neural stem cells (NSC) are multipotent cells that have
been derived from human embryonic stem cells as well as isolated
from fetal tissues [3], [4]. Such cells are viewed as a possible source
of neurons for a cell-based therapy of neurodegenerative disorders,
such as Parkinson’s disease (PD).
In appropriate culture conditions, NSCs can differentiate into
specialized cells, including dopaminergic (DA) neurons [5]. A
cocktail of growth factors and forskolin increase the conversion of
mesencephalic cells [6] to DA neurons. Bcl-Xl and hematopoietic
cytokines have been demonstrated to enhance the differentiation
of NSCs into DA neurons [7], [8]. Lee et al. [9] established the
five-stage differentiation method to induce the embryonic stem
cells (ESCs) into DA neurons. Transcription factors like Nurr1 [5]
and Pitx3 [10] were introduced into stem cells to enhance the the
proof-of- principle for developing different types of allogenic
neurons including personalized DA neurons for replacement
therapy in PD.
Genome-wide gene expression profiling can be used, providing
a more efficiency of DA neuron production. Moreover, the
methods to make human DA neurons from human ESCs (hESCs)
were established by co-culturing with PA-6 stromal cells [11], [12].
The recently developed protocol of direct reprogramming of adult
human somatic cells such as fibroblasts into induced pluripotent
stem cells (iPSCs) [13] provided comprehensive molecular
understanding of neural differentiation into DA. In-depth
examinations of gene expression profiles of embryonic NSC and
differentiated DA are likely to reveal information about the
‘‘stemness’’ as well as the pathways involved in DA differentiation.
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investigate for their role in DA differentiation. In addition, such
data are crucial for application to recently reported direct
reprogramming protocols, with an overall aim of directly
transforming somatic and neural stem cells into more differenti-
ated DA that could be used in cell-replacement therapies.
Whole genome analysis for the process of dopaminergic
differentiation from human embryonic NSC has not been
reported. To assess the properties of embryonic NSC, and to
provide insight about the process of DA differentiation, we
employed a whole genome analysis of embryonic NSC, and total
RNA isolated from adult human substantia nigra which is rich in
dopaminergic cells using Agilent and Illumina Whole Human
Gene Expression Microarray (http://www.genomics.agilent.com,
http://www.illumina.com ). These microarrays are based on
updated transcriptome databases for mRNA targets, and also
include probes for lincRNAs (long intergenic non-coding RNAs).
With the combination of mRNA and lincRNAs, it is now possible
to perform two experiments on a single microarray, confidently
predicting lincRNA function. We used this DNA array platform to
analyze embryonic NSC populations that were derived from
hESC, and DA cell that were isolated from the adult human
substantia nigra. The results were also compared with data from
various databases. This approach has allowed us to confirm the
consistency of our obtained results for a large number of genes that
delineate the phenotypical differences of embryonic NSCs, and SN
cells.
By comparing human embryonic NSC populations and SN cells
in the human substantia nigra, we identified 13525 genes that are
differentially expressed between the two cell populations. Approx-
imately 3737 genes were up-regulated in the embryonic NSC, and
4116 genes were up-regulated in SN cells. Comparison with data
sets developed by profiling of the two cell populations showed clear
differences, and a series of unique NSC and DA markers were
identified. Overall, our data suggest that in comparison to hENSC
which showed augmentation of genes involved in regulation of cell
cycle and mitosis, the SN cells displayed over-expression of genes
related to midbrain development, and DA production.
Materials and Methods
Human Embryonic Neural Stem Cells in Culture
Two cryopreserved human embryonic neural stem cells were
obtained from Invitrogen (Carlsbad, CA USA) as a commercially
available product (N7800-200). The cells were derived from NIH
approved H9 (WA09) human embryonic stem cells (hESCs).
Three more hENSCs samples were obtained from Dr. Philip
Schwartz at National Human Neural Stem Cell Resource,
Children’s Hospital of Orange County Research Institute, CA
(NIH grant HD059967). The cells were plated in a 6-well culture
plate coated with polyethyleneimine, and incubated at 37uCi na
5% CO2/95% air incubator in serum-free DMEM/F-12 medium
(Invitrogen, Carlsbad, CA, USA) supplemented with a mixture of
insulin–transferrin–selenium (ITS) (Invitrogen, Carlsbad, CA,
USA), 20 ng/ml recombinant human EGF (Invitrogen, Carlsbad,
CA), 20 ng/ml recombinant human bFGF (Invitrogen, Carlsband,
CA), and 10 ng/ml recombinant human LIF (Invitrogen, Carls-
band, CA), according to the methods described previously [14].
Half of the medium was renewed every 4 days. Following
incubation for several months, the embryonic NSC in culture
continued to proliferate by forming free floating or loosely
attached growing spheres.
For microarray analysis, non-passage embryonic NSC spheres
were harvested, replated in a non-coated 6-well culture plate, and
incubated further for 72 h in the NSC medium with or without
inclusion of 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad,
CA, USA).
Gene expression Profiling and Microarray Analysis
RNA Sample Preparation. Total cellular RNA was isolated
from embryonic NSC (n=5) using Trizol (Invitrogen). The RNA
quantity was analyzed using the Nano Drop ND1000 (SOP Nu
TAL009) and the RNA quality is checked using the Bioanalyzer
2100 (Agilent). Total RNA derived from adult human substantia
nigra (n=5) was purchased from Clontech (Palo Alto, CA, http://
www.clontech.com).
Sample amplification was performed with 200 ng of total RNA
using Agilent’s Quick Amp Labeling Kit OnoColor to generate
complementary RNA (cRNA) for oligo microarrays. cRNA was
processed for microarray analysis on a Whole Human Genome
Oligonucleotide Microarray (G4112A, 41,000 genes; Agilent
Technologies, Santa Clara, CA, USA, and Illumina, USA),
according to the manufacturer’s instructions.
Microarray Hybridization
The arrays were hybridized at 60uC for 17 h with the Tecan HS
Pro hybridization station in the hybridization buffer containing
fluorescence-labeled cRNA.
The microarrays were washed once with 63 SSPE buffer
containing 0.005% N-laurylsarcosine for 1 min at room temper-
ature followed by a second wash with pre-heated 0.066 SSPE
buffer (37uC) containing 0.005% N-laurylsarcosine for 1 min. The
last washing stage was performed with acetonitrile for 30 sec.
Image and Data Extraction
Fluorescence signals of the hybridized microarrays were
detected using Agilent’s and Illumina DNA microarray scanner
(Agilent and Illumina Technologies) with a resolution of 5 lM.
Agilent Feature Extraction Software (FES) was used to read out
and process the microarray image files. The software determines
feature intensities and normalized ratios by linear LOWESS with
background subtraction, rejects outliers and calculates statistical
confidences (P-values). A quality control was performed at this
stage. Genes with a P-value smaller than 0.001 were considered
significant. Only genes differentially expressed in the ten
experiments were considered as relevant genes.
MIAME
Data were submitted to GEO archive (gene expression
omnibus) according to MIAME (Minimum Information About a
Microarray Experiment) recommendation. A GEO accession
number was assigned: GSE25931.
Data Mining
Data were processed with GeneSpring GX 10.0.2 software
(Agilent Technologies). A fold change (FC).2 and a P value,0.01
resulted in a selection of 13525 mRNA. Among them, 3737 were
up-regulated in embryonic NSC and 4116 were up-regulated in
SN cells. For data visualization, hierarchical clustering was
performed with the Pearson metric and complete linkage method.
Gene ontology was performed in GeneSpring to identify
overrepresented GO-classes compared with the human whole
genome, i.e: molecular function, biological process and cellular
component [15], [16]. Whole Human Genome was used as the
reference group. Statistical significance was calculated with a
standard hypergeometric distribution corrected by a Benjamini
Yekutelli correction for multiple testing which takes into account
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considered GO-paths was 2. Significance was set at corrected P-
value ,0.05.
Pathway analysis was used to find direct relationships between
entities of interest. This was performed in GeneSpring with the
‘‘simple and direct interaction’’ algorithm. The information was
obtained from the literature using Natural Language Processing
algorithms to search PubMed abstracts.
Hierarchical clustering of these differentially expressed genes
was conducted using the software, Cluster 3.0, with centroid
linkage and visualized using Tree View. (http://bonsai.ims.
utokyo.ac.jp/mdehoon/software/cluster/software.htm). Principle
component analysis (PCA) was conducted using the bioconductor
packages (www.bioconductor.org).
Functional Annotation and Molecular Network Analysis
Raw and processed gene expression data have been deposited in
NCBI’s Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/, GEO Series accession number GSE25931). Whole
human genome arrays from human embryonic NSC, and SN cells
underwent weighted averaging by Rosetta Resolver software to
produce an average differential expression ratio for every gene.
Although there are cases on the array where more than one probe
is used to query different parts along the sequence of a single gene,
and in some instances, identical probes to the same gene are
replicated mainly for QC purposes, the vast majority of genes are
queried using a single probe with the Agilent and Illumina
platform. Functional annotation of significant genes identified by
microarray analysis was searched by the web-accessible program
named Database for Annotation, Visualization and Integrated
Discovery (DAVID) version 2009, from the National Institute of
Allergy and Infectious Diseases (NIAID (NIH) (david.abcc.ncifcrf.
gov) [17], [18]. DAVID covers more than 40 annotation
categories, including Gene Ontology (GO) terms, protein–protein
interactions, protein functional domains, disease associations,
biological pathways, sequence general features, homologies, gene
functional summaries, and tissue expressions. By importing the list
of the National Center for Biotechnology Information (NCBI)
Entrez Gene IDs, this program creates the functional annotation
chart, an annotation-term-focused view that lists annotation terms
and their associated genes under study. To avoid excessive count
of duplicated genes, the Fisher’s exact test is calculated based on
corresponding DAVID gene IDs by which all redundancies in
original IDs are removed. Gene ontology (GO) and KEGG
molecular pathway analysis was performed to identify possible
enrichment of genes with specific biological themes using both the
data set as a whole and then in the individual K-means clusters.
DAVID calculates a modified Fishers Exact p-value to demon-
strate GO or molecular pathway enrichment, where p-values less
than 0.05 after Benjamini multiple test correction are considered
to be strongly enriched in the annotation category.
Correlation with other Gene Expression Data from
Various Databases
Additional expression data sets in form of CEL-files were
obtained from the web (http://www.ncbi.nlm.nih.gov/geo/) or
(http://wombat.gnf.org/suppl.html#reqdata_geneatlas). Data-
sets included the NCI60-dataset (http://wombat.gnf.org/samples/
NCI60_sample_info.htm), the GNF-SymAtlas [19] and the
‘‘breadth-of-expression’’ dataset [20]. Own experimental data and
external data were put together and low-level-corrected using the
RMA-algorithm [21]. Expression data were then exported in log2-
scale. In addition, individual expression profiles were fitted by
means of median polish to a reference profile in regard to intensity
distribution and RNA quality. Over-expressed genes were deter-
mined to exceed a minimal difference of 2.5 (in log2-scale) between
their individual intensity and the median intensity of all analyzed
chips. Only genes over-expressed in all chips for each respective cell
type were used for analysis and comparison with other data. To
detect relevant statistical differences/similarities within the main
cluster of neural tissues, we extracted the expression profiles derived
from all available neural tissues for further statistical analyses, while
keeping the changes introduced by the global normalization
procedure.
Pathway Analysis
762 pathways (BioPax format pathways with .owl extension)
were imported into GeneSpring GX from reactome database
(reactome.org) to perform ‘‘find significant pathways’’ tool. This
tool allows to investigate if there is a significant enrichment of my
genes of interest in a particular pathway. The p-value is calculated
using the hypergeometric distribution.
Results
Obtaining and Characterizing Samples
Ten cell samples were selected and subdivided into two groups.
The first group was composed of five samples of hESC. As
representatives of dopaminergic neurons, we had included five
RNA samples collected from normal human brain (substantia
nigra) that are known to be rich in dopaminergic neurons. The
total RNA samples of adult human substantia nigra for the first
two samples were pooled from 19 male/female Caucasians, ages:
25–64 whose cause of death was given as ‘‘sudden death.’’ The last
three samples of human SN were collected on an individual base
from male Caucasians, ages: 25, 53, and 67.
Based on previous characterization by Invitrogen, the human
neural stem cells used in the present study were self-renewing,
multipotent stem cells of the nervous system derived from the NIH
approved H9 (WA09) human embryonic stem cells (hESCs). The
cells retain their normal female human karyotype and their
potential to differentiate into neurons and glial cells after multiple
passages. They stain positive for the neural stem cell-type specific
markers nestin and SOX2, the proliferation marker Ki67 (.80%),
and for embryonic stem cell-specific marker Oct4 (#5%) (Fig. 1).
The hNSCs spontaneously differentiate into neurons, oligoden-
drocytes, or astrocytes upon withdrawal of bFGF and EGF from
culture media. Alternatively, they can be enriched toward a
specific lineage upon selection on differentiation medium.
Based on previous characterization by Clontech, the total RNA
from human substantia nigra was analyzed by capillary electropho-
resis (CE) using an Agilent 2100 Bioanalyzer. RNA concentration and
purity were evaluated by UV spectrophotometry. Both the area ratio
of the 28S/18S rRNA peaks, and the proportion (relative percentage)
of these two peak areas to the total area under the electropherogram
provide reliable quantitative estimates of RNA integrity.
Data Acquisition Analysis and Verification
We used Whole Human Genome Oligonucleotide Microarray
(G4112A, 41,000 genes; Agilent and Illumina Technologies, USA)
to monitor gene expression in human embryonic NSC, and
human SN cells which are known to be rich in dopaminegic
neurons.
The Whole Human Genome Oligo microarray is comprised of
approximately 41,000 (60-mer) oligonucleotide probes, which span
conserved exons across the transcripts of the targeted full-length
genes. These probes represent the human genome, full-length and
partial human genes from a number of major public sources. The
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product is available through Agilent, Illumina and publicly-available
databases such as RefSeq, GoldenPath, Ensembl and more.
Correlation, Cluster Analysis and Comparison of hENSC
with Human SN Cells
Heatmap correlation, hierarchical clustering analysis, principal
component analysis (PCA), and scatter-plot were conducted using
GeneSpring GX Software. Heatmap correlation (Figure 2a), a
dendrogram analysis (Figure 2b), scatter-plot (Figure 2c, and PCA
(Figure 2d) illustrate that hENSC samples clustered together and
could be discriminated from human SN cells analyzed in this
study. From all these data, we concluded that the overall gene
expression profile seen in hENSC could be discerned from that
seen in human substantia nigra dopaminergic cells.
RNA extracted from human embryonic NSC and adult human
substantia nigra was used to produce cDNA and hybridized to
Agilent’s and Illumina Whole Human Genome microarray. Genes
expressed differentially between hENSC and SN cells were
identified using two criteria: those with a greater than 2-fold
difference in normalized expression between the two cell
populations, and those that were flagged ‘‘present’’ at one type
and ‘‘absent’’ at the other.
We considered only genes that were regulated at least two-fold
in a significant manner based on replicate hybridizations (p,0.05).
Using these criteria, we identified 1830 up-regulated and 1932
down-regulated mRNA in DA SN vs hE_NSC.
Of these, the top ten most differentially expressed probe sets
determined using the two approaches are shown in Table S1 for
hENSC and for SN cell. Genes in all tables were categorized,
annotated and their GO analysis was carried out based on
functional information obtained in online databases.
We found that the set of genes expressed more highly in hENSC
is enriched in molecules known or predicted to be involved
in GO:0000166: nucleotide binding, GO:0003723: RNA
binding, GO:0005515: protein binding, GO:0005634: nucleus,
GO:0005737: cytoplasm, GO:0017148: negative regulation of
translation, GO:0042035: regulation of cytokine biosynthetic
process, GO:0045182: translation regulator activity, GO:0048027:
mRNA 59-UTR binding, GO:0000087: M phase of mitotic cell
cycle (Table 1, and Table S1). This suggests that at hENSC are in a
state of active metabolism and growth, and some of them may
potentially still be undergoing proliferation. The higher expression
level of ribosomal genes is alsoindicative of cells in a state of growth.
On the other hand, the genes enriched in SN samples include a
different set of functional categories, namely GO:0007268:
synaptic transmission, GO:0007417: central nervous system
development, GO:0019911: structural constituent of myelin
sheath, GO:0033269: internode region of axon, GO:0042552:
myelination, GO:0042995: cell projection, GO:0043025: cell
somata, GO:0043209: myelin sheath, GO:0005783: endoplasmic
reticulum, GO:0005789: endoplasmic reticulum membrane,
GO:0005792: microsome, GO:0006633: fatty acid biosynthetic
process, GO:0006665: sphingolipid metabolic process, GO:
0006810: transport, extracellular region, GO:0006811: ion tran-
sport, GO:0031643: positive regulation of myelination, GO:
0001518: voltage-gated sodium channel complex, GO:0005244:
voltage-gated ion channel activity, GO:0005248: voltage-gated
sodium channel activity, GO:0006811: ion transport, GO:
0006814: sodium ion transport, GO:0007268: synaptic transmis-
sion. (Table S1, and Table S2). This result suggests that a key role
of DA in the adult human substantia nigra is to support/modulate
synaptic transmission, central nervous system development, myelin
sheath formation, and voltage-gated ion channel activity where we
identified some potential molecular players that may mediate this
role.
An overview of Human Embryonic Neural Stem Cells
Transcriptome
We started our DNA microarray data analysis by studying
expression level of the generally accepted stem cell markers such as
POU, transcription factor 1 (Oct3/4), teratocarcinoma-derived
Figure 1. Fluorescence image (206) of GIBCOR hNSCs at
passage 3 that have been cultured in StemProR NSC SFM
and stained for the NSC phenotype markers nestin (green) and
the proliferation marker Ki67 (red, a). Cell nuclei were counter-
stained with DAPI (blue,a). Approximately 90% of the cells stain positive
for the undifferentiated NSC marker nestin and the proliferation marker
Ki67. Lack of Oct4 staining indicates that there are no remnant hESCs in
the culture (data not shown) (Invitrogen, Manual part no. A11592,
MAN0001758). Fluorescence images (206) of GIBCOR hNSCs that have
been cultured in StemProR NSC SFM for three passages, and then
allowed to differentiate into neurons, oligodendrocytes, or astrocytes.
Upon directed differentiation, cells start to lose the undifferentiated
NSC marker, nestin, but stain positive for the differentiated cell type
markers Dcx, GalC, and GFAP. Cells were stained for the undifferentiated
NSC markers nestin (red, b) and SOX2 (green, c) prior to directed
differentiation. Cell were then differentiated into neurons and glial cells,
and respectively stained for the neuronal marker Dcx (green, c), for the
oligodendrocyte marker GalC (red, d), or for the astrocyte marker, GFAP
(green, e). The nuclei were counterstained with DAPI (blue) in panels B–
D (Invitrogen, Manual part no. A11592, MAN0001758).
doi:10.1371/journal.pone.0028420.g001
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embryonic cell transcription factor 1 (Utf1), and DNA methyl-
transferase 3B (Dnmt3b) in samples of hENSCs. The POU
domain, and DNA methyltransferase 3B (Dnmt3b) were signifi-
cantly increased to 2.80, and 4.44 fold respectively. Class 5,
transcription factor 1 (Oct3/4), signal transducer and activator of
transcription 3 (Stat3), teratocarcinoma-derived growth factor
(Tdgf1), Enk-pending (Nanog), undifferentiated embryonic cell
transcription factor 1 (Utf1) were not significantly increased. These
results might indicate the absence of any undifferentiated ESC
within our hENSC samples used.
To further test for the presence of undifferentiated embryonic
stem cell markers, samples from hENSC were assayed for the
presence of the endodermal gene AFP and the mesodermal gene
Eomes. The AFP, and Eomes were not significantly increased in
hENSC samples. Eomes was increased by 2.82 fold in our human
substantia nigra cells which is quite logical, taking into
consideration the mesodermal origin of some types of glial
(microglia) cells, which are known to co-exist with DA cells. The
differentiation status of hENSC was also checked by the expression
level of the lineage markers of three layers: T (brachyury) for
mesoderm, Nodal for ectoderm, and Gata4 (GATA binding
protein 4) for endoderm. None of them were significantly
increased in our examined samples of ENSC.
Next, we studied markers of NSC such as Nestin, Sox1, Sox2,
CD133, and Musashi1. Nestin, Sox1, Sox2, Musashi1 were
increased 3.19, 2.58, 2.23, 1.49 fold respectively, while CD133 was
not significantly increased.
Of the 17 SOX-family transcription factors present on the
array, only SOX1, 11, 12, and 13, which exhibit neural tube/
progenitor expression or function, were detected and increased
4.66, 5.71, 2.58, and 3.04 fold respectively.
Next, we tested the undifferentiated nature of hENSC by
examining the expression profile of more mature neuronal
markers such as choline acetyltransferase, tyrosine hydroxylase
(TH) or those of late glial markers such as glial fibrillary acidic
protein (GFAP), myelin associated glycoprotein (MAG), and
oligodendrocyte transmembrane (OSP). We did not detect
expression of any of the more mature neuronal and glial markers
in the hENSC samples, suggesting that the neural cells in the
sample were indeed undifferentiated NSC.
Next, we chose a set of regulated genes that are associated
with NSC proliferation or differentiation. Cystatin C acts as a
necessary cofactor for FGF-2 in neural stem cells [22]. The
Figure 2. The correlation between human embryonic neural stem cells (StemCells_1,2) and dopaminergic cells (Brain_1,2), and also
among the two arrays of the same sample. There was no correlation (yellow colors) between hENSC and DA cells samples. But there was a
strong correlation (blue colors) between the arrays from the same samples (A). Hierarchical clustering analysis using GeneSpring GX Software.
Hierarchical clustering dendrogram of relative gene expression in different populations was generated using the GeneSpring GX Software (B). hENSCs
(stem_1, and stem_2) clustered together and are distinguished from human substantia nigra dopaminergic cells (Brain_1, and Brain_2). Unsupervised
hierarchical clustering based on overall gene expression profiles reveals two distinct clusters corresponding to the two cell groups. This suggests that
the samples from the two cell types (hENSC vs DA cells) do indeed represent two statistically distinct populations suitable for valid comparison.
Scatter-plot used to quickly identify discrepancies in gene expression profiles between hENSC and DA cells from human substantia nigra (C). Both cell
populations could be clearly discriminated based of differences in their gene expression profiling. Principal component analysis (PCA) which is useful
when we expect samples to be linearly (or even monotonically) related to each other (D). As you see here samples from the hENSC and from human
subastantia nigra DA cells are completely different.
doi:10.1371/journal.pone.0028420.g002
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substantia n i g r ac e l l sb u ts h o w e dn os ignificant increase in
hENSC, further indicating the undifferentiated nature of
hENSC samples. Synaptotagmin XI belongs to a family of
proteins involved in synaptic vesicle trafficking. The increase in
expression of synaptotagmin XI as differentiation proceeded
was confirmed where it was increased by 2.5 fold in human
substantia nigra cells but showed no significant increase in
hENSC. Myelin proteolipid protein, PLP, is an integral
membrane protein that accounts for 50% of the protein mass
in the myelin sheath. The expression of PLP1, and PLP2 was
stimulated by 6.71, and 3.88 fold respectively in human
substantia nigra cells, but were not detected in hENSC samples.
In contrast, no significance up-regulation of genes related to
various extracellular matrix proteins, such as various collagen
isoform and other genes related to connective tissue and its
metabolism (LOXL1, LOXL2, and LUM) was encountered. Also,
genes related to fully differentiated neural tissue like the
hippocampus expressed neuronal and glial genes like NTRK2,
NTRK3, MBP, and GFAP were not demonstrated.
The genomic profiling of our hENSC line was characterized by
a lower expression of MHCII genes and myelin components such
as peripheral myelin protein two (PMP2), myelin-associated
glycoprotein (MAG), or the myelin-oligodendrocyte glycoprotein
(MOG). However, PMP2, PMP22 and MOG were up-regulated
to 10.17, 4.43, and 9.70 fold respectively in SN cells. Interestingly,
this study revealed that CD44 and GDF1/LASS1 were not
expressed in hENSCs line. Our data revealed that genes specific
for differentiated neurons such as SNAP25 and neurogranin
(NRGN) were markedly up-regulated to 7.49 fold in SN cells,
while it was not detected in hENSCs. In the present study, genes
specifically expressed in adult NPCs such as low-affinity nerve
growth factor receptor precursor (p75, NGFR), Nestin (NES), the
dual specific phosphatase 10 (DUSP10), the CCmotif containing
chemokine receptor seven (CCR7), the transcription factor four
(TCF4), the G protein-coupled receptor 17 (GPR17), and the
chondroitin sulfate proteoglycan four (CSPG4) were specifically
under-expressed in hENSCs line.
An overview of Human Subastantia nigra Dopaminergic
Cells Transcriptome
The substantia nigra sample used in the present study is a total
mRNA extracted from dissected human SN, and not from DA
neurons isolated from such tissue so it is rich in DA, and glial cells
with nearly an entire absence of NSC. First, we checked the
expression of neuronal and glial markers. Tubulin beta 2A and
tubulin beta 4 were increased by 2.26, and 5.66 fold respectively.
The glial fibrillary acidic protein (GFAP) gene was increased by
14.18 fold. Neurogenic differentiation 1 (NeuroD1), is a transcrip-
tion factor that indicated the commencement of neural differen-
tiation: It was significantly increased by 3.43 fold.
The genes related to midbrain development, such as Nr4a2
(nuclear receptor subfamily 4, group A, member 2, Nurr1) and
En1 (engrailed 1) were increased 3.76, and 6.41 fold respectively.
In addition, the transcriptions of the genes such as Ddc (dopamine
decarboxylase, AADC), Slc6a3 (solute carrier family 6, member 3,
DAT), and Th (tyrosine hydroxylase) were significantly increased
to 8.08, 4.01, and 5.91 respectively.
We also scrutinized gene expression in human substantia nigra
and found many transcripts that were unregulated in them. Many
of these genes have known or presumed function during neural
development and differentiation, including FGF signaling (FGF3,
FGFR2, FGFR12) which were increased by 2.16, 3.66, 3.71 fold
respectively. WNT signaling (FZD3) was not significantly
increased in human substantia nigra. Neurogenic functions
(DLK1, VEGF) were increased 3.20, 2.37 fold respectively, and
neurotrophin signaling (NTRK2) was increased to 3.40 fold.
Common markers of neuronal cell function were also up-regulated
such as neurofilaments NEFL, MAP2, and NCAM1 which were
increased by 4.30, 2.10, 14.16 fold respectively. Consistent with
this, the midbrain dopaminergic marker LMX1B (LIM homeobox
transcription factor 1, beta) was increased 2.42 fold.
Several transcription factors that are involved in the specifica-
tion of the midbrain dopaminergic lineage, EN1, and LMX1B,
were all expressed at higher levels in our human substantia nigra,
at approximately 6.41, 2.42 fold, respectively.
Interestingly, the GIRK2 channel protein (a marker of A9
dopaminergic neurons) [23], which is the major dopamine neuron
subtype depleted in Parkinson’s disease [24], [25], [26] was not
detected in our human substantia nigra samples. Expression of
DbH, a more specific marker for other catecholaminergic neurons,
was also not significantly increased. This expression analysis
suggested elevated expression of dopaminergic transcription
factors and some markers of differentiated neurons in our
examined samples of human SN cells.
Next, we studied the expression profiling of more than 28 genes
(Table S2) that are modulated in the dopaminergic system.
Functional Annotation Clustering of hENSC
Functional annotation of significant genes identified by micro-
array analysis was searched by the web-accessible program named
Database for Annotation, Visualization and Integrated Discovery
(DAVID) version 2009. Clustering for the top 1200 unregulated
genes (Log2 5–12) of hENSC using DAVID, we identified 110
annotation clusters. The annotation cluster 1 (Table 1) showed the
highest enrichment score of 27.56 and included genes related to M
phase, cell cycle, cell cycle phase, cell cycle process, mitosis.
Functional Annotation Clustering of Substantia nigra
Dopaminergic Cells
Clustering for the top 1200 unregulated genes (Log2 5–14) of
substantia nigra samples using DAVID identified 185 Cluster
Table 1. Functional Annotation Clustering using DAVID for




Score 27.56 Count P_Value Benjamini
GOTERM_BP_FAT M Phase 63 2.2E-47 3.9E-44
GOTERM_BP_FAT cell cycle 87 2.5E-47 2.2E-44
GOTERM_BP_FAT cell cycle phase 67 1.1E-45 6.5E-43
GOTERM_BP_FAT cell cycle process 74 3.1E-44 1.4E-41
SP_PIR_KEWORDS mitosis 47 2.4E-42 8.0E-40
GOTERM_BP_FAT mitosis 50 6.2E-41 2.2E-38
GOTERM_BP_FAT nuclear division 50 6.2E-41 2.2E-38
SP_PIR_KEWORDS cell cycle 64 7.1E-41 1.2E-38
One hundred ten annotation clusters were obtained. The annotation cluster
one included M phase, cell cycle, cell cycle phase, cell cycle process, mitosis
with an enrichment score of 27.56. On the very right you find the Benjamini
corrected enrichment score; the lower the better. The functional annotation
tool now allows several methods for adjusting p-values for multiple testing. The
Benjamini–Hochberg–Yekutieli procedure controls the false discovery rate
under dependence assumptions.
doi:10.1371/journal.pone.0028420.t001
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highest enrichment score of 13.07 and included genes related to
glycoproteins, disulphide bonds, and signals. The annotation
cluster group 4 (Table 3) with an enrichment score of 7.58 contains
genes related to neuronal cell functions and differentiation such as
transmission of nerve impulses, synaptic transmission, cell-cell
signaling, and neurological system processes. The transmission of
nerve impulse group included genes that regulate the neurological
system process by which a signal is transmitted through the
nervous system by synaptic transmission and the sequential
electrochemical polarization and depolarization that travels across
the membrane of a nerve cell (neuron) in response to stimulation.
The annotation cluster group 50 with an enrichment score of
1.36 contains genes specific to dopaminergic neurons such as
GABA receptor activity (5 genes), postsynaptic cell membrane (20
genes), neurotransmitter binding (9 genes), ligand-gated ion
channel activity (10 genes), GABA-A receptor activity (4 genes),
gamma-aminobutyric acid signaling pathway (4 genes), and
Gamma-aminobutyric acid A receptor (4 genes).
Gene ontology (GO) of hE_NSC and human Substantia
nigra Dopaminergic Cells
Gene ontology (GO) and KEGG molecular pathway analysis
was performed to identify possible enrichment of genes with
specific biological themes using both the data set as a whole and
then in the individual K-means clusters. DAVID calculates a
modified Fishers Exact p-value to demonstrate GO or molecular
pathway enrichment, where p-values less than 0.05 after
Benjamini multiple test correction are considered to be strongly
enriched in the annotation category. GO clustering using DAVID
for the top 1200 unregulated genes (Log2#5–12) of hENSC. Forty
clusters were obtained that include ATP binding (62 genes), adenyl
ribonucleotide binding (62 genes), adenyl nucleotide binding (63
genes), purine nucleoside binding (63 genes), nucleoside binding
(63 genes), ribonucleotide binding (63 genes), purine ribonucleo-
tide binding (63 genes), purine nucleotide binding (64 genes),
nucleotide binding (71 genes) and others.
Gene ontology (GO) and KEGG molecular pathway analysis
was performed to identify possible enrichment of genes for human
substantia nigra dopaminergic cells.
GO clustering using DAVID for the top1200 unregulated genes
(Log2#5–12) of dopaminergic cells. Ninety one clusters were
obtained that include channel activity (31 genes), passive
transmembrane transporter activity (31 genes), substrate specific
channel activity (29 genes), gated channel activity (25 genes),
GABA receptor activity (5 genes).
KEGG Pathway Analysis of hE_NSC and Human
Substantia Nigra
The 1830 up-regulated and 1932 down-regulated mRNA in SN
vs hE_NSC were submitted to ‘‘find significant pathways’’ tool
into GeneSpring GX. Twenty-one pathways were significantly
found in the 1830 up-regulated mRNA set, among them we noted
‘‘dopamine neurotransmitter release cycle’’ (Figure 3). Ninety-one
pathways were significantly found in the 1932 down-regulated
mRNA set, among them we noted ‘‘M phase’’ (Figure 4).
KEGG pathway analysis of the top 1200 up-regulated genes
(Log2#5–12) of hENSC showed significant enrichment for eight
molecular pathways: cell cycle, oocyte meiosis, p53 signaling
pathway, progesterone-mediated oocyte maturation, viral myo-
carditis, ABC transporters, vibrio cholerae infection, and homol-
ogous recombination.
The cell cycle pathway contained 22 genes representing 6.6% of
the genes detected by KEGG pathway analysis. The cell cycle
pathway is dominated by genes regulating cell proliferation and
mitosis such as E2F transcription factor 2, TTK protein kinase,
Table 2. Functional Annotation Clustering using DAVID for the top1200 unregulated genes (Log2#5–12) of human substantia
nigra.
Annotation Cluster 1 Enrichment Score 13.07 Count P_Value Benjamini
SP_PIR_KEWORDS glycoprotein 187 9.9E-19 4.7E-16
UP_SEQBP_ FEATURE glycosylation site:Nlinked 176 3.2E-16 4.5E-13
SP_PIR_KEWORDS disulfide bond 129 1.6E-12 1.9E-10
SP_PIR_KEWORDS signal 138 3.2E-12 3.0E-10
SP_PIR_KEWORDS signal peptide 138 5.1E-12 1.4E-9
UP_SEQBP_ FEATURE disulfide bond 122 4.8E-11 41E-8
Annotation Cluster 2 Enrichment Score 11.7 Count P_Value Benjamini
SP_PIR_KEWORDS glycoprotein 187 9.9E-19 4.7E-16
UP_SEQBP_ FEATURE glycosylation site:Nlinked 176 3.2E-16 4.5E-13
SP_PIR_KEWORDS membrane 231 3.1E-15 7.4E-13
UP_SEQBP_ FEATURE topological domain:Cytoplasmic 147 8.4E-14 5.7E-11
UP_SEQBP_ FEATURE transmembrane region 187 1.9E-12 8.8E-10
UP_SEQBP_ FEATURE topological domain:Extracellular 123 1.9E-12 6.6E-10
SP_PIR_KEWORDS transmembrane 187 3.5E-12 2.8E-8
GOTERM_CC_FAT plasma membrane 166 1.7E-10 1.8E-6
GOTERM_CC_FAT intrinsic to membrane 209 5.2E-8 3.3E-6
GOTERM_CC_FAT integral to membrane 198 1.1E-6 4.3E-5
185 clusters were obtained. The annotation cluster 1 showed the highest enrichment score of 13.07 and included genes related to glycoproteins, disulphide bond, and
signals.
doi:10.1371/journal.pone.0028420.t002
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to S and G2 to M, cyclin A2, cyclin B1, cyclin B2, cyclin-
dependent kinase 2, pituitary tumor-transforming 1; pituitary
tumor-transforming 2, protein kinase CHK2-like; and tumor
suppressor protein p53.
The enriched molecular pathways and GO categories identified
for hENSC were predominantly driven by genes in the cluster up-
regulated with dramatic changes ranging from 5–12 fold increases in
expression. In addition to genes involved in cell proliferation and cell
division regulation such as TTK protein kinase, c-abl oncogene 1,
receptor tyrosine kinase, cell division cycle 2, G1 to S and G2 to M,
cyclin A2, cyclin B1, cyclin B2, cyclin-dependent kinase 2, protein
kinase CHK2-like, several genes related to tumor transformation and
tumor control were also encountered such as pituitary tumor-
transforming 1 and pituitary tumor-transforming 2 and tumor
suppressor protein p53. The differential expression of these genes is
probably result of the embryonic nature of our examined cell lineage.
KEGG pathway analysis of the top1200 unregulated genes
(Log2#5–12) of SN samples showed significant enrichment for 24
molecular pathways: cell adhesion molecules (CAMs), (16 genes),
neuroactive ligand-receptor interaction (17 genes), tyrosine
metabolism (6 genes), beta-Alanine metabolism (4 genes), trypto-
phan metabolism (5 genes), and calcium signaling pathway (11
genes). The cell adhesion molecules (CAMs) pathway contained 16
genes representing 1.3% of the genes detected by KEGG pathway
analysis. The cell adhesion molecules (CAMs) pathway is
dominated by genes in the cluster up-regulated with dramatic
increases ranging from 5–12 fold. The genes are involved in
regulation of neuronal pre-and postsynaptic activities as well as
Schwann cells and oligodendrocyte differentiation such as neural
cell adhesion molecule 1, contactin 1, and contactin 2 (axonal),
and claudin 11.
We next examined the top 15 up-regulated genes in both
human embryonic NSC, and SN samples. In hENSC the most up-
regulated, gene showing a 12.17 fold increase was insulin-like
growth factor 2 mRNA binding protein 1. This gene encodes a
member of the insulin-like growth factor 2 mRNA-binding protein
family. The protein encoded by this gene contains four K
homology domains and two RNA recognition motifs. It functions
by binding to the mRNAs of certain genes, including insulin-like
growth factor 2, beta-actin and beta-transducin repeat-containing
protein, and regulating their translation.
The over expression of GFAP might indicate the presence of
some glial cell contamination within our examined human SN
samples. In addition, the significant 12.57 fold increase in
apolipoprotein D might indicate susceptibility for Alzheimer’s
disease in our examined human SN cells.
One focus of our study was to characterize a complex series of
signaling programs potentially involved in the priming process of
hNSCs. A better understanding of these signaling pathways at a
cellular level would be of great assistance to the elucidation of the
mechanisms underlying stem cell lineage specification and to the
discovery of potential targets for stem cell therapy, gene therapy
and pharmaceuticals. The signaling molecules changed during
differentiation of hNSC into SN samples were including Wnt, and
Notch pathways.
Notch signaling pathway has been reported widely to regulate
cell fate determination, cell polarity and differentiation. Notch
pathway components were regulated differently. For example, the
transcription factor enhancer of split and the ligand deltex, and
Table 3. Functional Annotation Clustering using DAVID for the top 1200 unregulated genes (Log2#5–12) of human substantia
nigra.
Annotation Cluster 4 Enrichment Score 7.58 Count P_Value Benjamini
GOTERM_BP_FAT transmission of nerve impulse 34 1.5E-10 3.3E-7
GOTERM_BP_FAT synaptic transmission 30 9.7E-10 1.1E-6
GOTERM_BP_FAT cell-cell signaling 43 4.7E-9 3.5E-6
GOTERM_BP_FAT neurological system process 51 6.9E-4 4.3E-2
Annotation Cluster 5 Enrichment Score 7.3 Count P_Value Benjamini
SP_PIR_KEWORDS cell adhesion 32 9.9E-19 2.1E-6
UP_SEQBP_ FEATURE cell adhesion 44 3.2E-16 7.5E-5
SP_PIR_KEWORDS Biological adhesion 44 3.1E-15 6.1E-5
Annotation Cluster 6 Enrichment Score 5.94 Count P_Value Benjamini
UP_SEQBP_ FEATURE signal 138 1.9E-12 3.2E-12
UP_SEQBP_ FEATURE signal peptide 138 1.9E-12 1.4E-9
SP_PIR_KEWORDS secreted 65 3.5E-12 4.3E-3
GOTERM_CC_FAT extracellular region part 48 1.7E-10 3.8E-3
GOTERM_CC_FAT extracellular space 37 5.2E-8 5.4E-3
GOTERM_CC_FAT extracellular region 75 1.1E-6 1.0E-1
Annotation Cluster 7 Enrichment Score 5.21 Count P_Value Benjamini
GOTERM_CC_FAT response to wounding 35 1.1E-6 3.6E-4
GOTERM_CC_FAT inflammatory response 26 1.3E-6 3.6E-4
185 annotation clusters were obtained. The annotation cluster group 4 with an enrichment score of 7.58 contains genes related to nervous system and neurons such as
transmission of nerve impulse, synaptic transmission, cell-cell signaling, and neurological system process.
doi:10.1371/journal.pone.0028420.t003
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were up-regulated to 2.02 fold in our hENSC samples.
Discussion
Only a limited number of genes are currently recognized as
established stem cell markers such as POU domain, class 5,
transcription factor 1 (Oct3/4), signal transducer and activator of
transcription 3 (Stat3), teratocarcinoma-derived growth factor
(Tdgf1), Enk-pending (Nanog), undifferentiated embryonic cell
transcription factor 1 (Utf1) and DNA methyltransferase 3B
(Dnmt3b) [27]. In the present study, genomic profiling of the
embryonic human NSCs showed significant over expression of
POU (2.80 fold), and DNA methyltransferase 3B (Dnmt3b) (4.44
fold). In contrast, no significant over expression was demonstrated
for transcription factor 1 (Oct3/4), activator of transcription 3
(Stat3), teratocarcinoma- derived growth factor (Tdgf1), Enk-
pending (Nanog), undifferentiated embryonic cell transcription
factor 1 (Utf1).
The non significant over expression of tumorigenic genes such
Oct3/4, Nanog, and Utf1 in the examined hE_NSC samples
might provide evidence for the non-tumorigenic nature of our
examined hENSC samples and their safety for use in cell-based
therapy for traumatic and neurodegenerative insults.
Recent studies have confirmed that Oct-3/4, SOX2, c-Myc,
and Klf4 are essential for the process of direct reprogramming of
somatic [28] and NSC to either induced pluripotent stem cells
(iPS), and to induced neurons such as cholinergic and dopami-
nergic ones [29]. The present study demonstrated that neither
Oct3/4 nor Klf4 were expressed in hENSC, SOX2, but c-Myc
were significantly over expressed by 3.17, and 3.19 fold
respectively. These results agree with those of Nakagawa et al.
[30] who reported that mouse neural stem cells have been shown
capable of reprogramming into a pluripotent state by forced
expression of Oct3/4 and Klf4 only; however it is unknown
whether this same strategy could apply to human NSCs, which
would result in more relevant pluripotent stem cells for modeling
human disease. Similar to mouse NSC, the significant over
expression of SOX2, and c-Myc that the present study revealed
might hint at the possibility of two factor reprogramming of
human neural stem cells into pluripotency using Oct3/4 and Klf4,
as has been previously demonstrated by Hester et al [31].
The expression profiles of known NSC genes were examined for
all hENSC samples used in this study. The overall expression
pattern of the selected genes was quite similar among the three
samples tested. All hENSC samples displayed expression of the
generally accepted markers of NSC Sox1, Sox2, Nestin, and
Musashi1. Hundreds of genes are suggested as candidate markers
Figure 3. Dopamine neurotransmitter release cycle pathway. The 1830 up-regulated mRNA set are significantly enriched by mRNA coding for
proteins involved in ‘‘dopamine neurotransmitter release cycle’’ pathway. The network was generated by ‘‘find significant pathway’’ function in
GeneSpring GX v11 (p,0.05). Connections were based on known interactions between these proteins within the Reactome database. The biological
relationship between two proteins is represented as a line (an edge). The proteins with a blue halo belong to the 1830 mRNA up-regulated set in
brain vs stem cells. Red and blue colored squares indicate genes with up- and down-regulated expression, respectively. The intensity of the colors
highlights the fold change (FC) in brain vs stem cells samples. The nature of the relationships between the proteins are shown in legend. SNAP25,
synaptosomal-assiociated protein 25; RIMS1, regulating synaptic membrane 1; RAB3A, RAB3A interacting protein; SYT1, synaptotagmin; CPLX1,
complexin 1; STXBP1, syntaxin binding protein 1.
doi:10.1371/journal.pone.0028420.g003
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state is not yet fully verified [32]. Considering the complexity of
the processes involved, stemness can hardly be ensured by
cooperation of just a few genes. Nevertheless, three stemness
genes (namely, Oct3/4, Stat3 and Nanog) are considered
‘‘master’’-genes that control the self-renewing process [33], [34].
Genome-wide gene expression profiling of an immortalized
human NSC clone named HB1.F3 F3 that stably overexpressing
Ngn1 identified 250 up regulated genes and 338 down regulated
genes in F3-Ngn1 versus F3-WT cells [35]. Notably, the
expression of LGR5, a recently identified marker for intestine
and hair follicle stem cells [36], [37], [38], was greatly elevated in
F3-Ngn1 cells at both mRNA and protein levels. In comparison to
these findings, our DNA data had not recorded any up-regulation
of Ngn1 or LGR5 in our hENSC, however, the LGR5 gene was
up-regulated to 4.30 folds level in SN cells. Our data correlate with
the notion that, transient overexpression of Ngn1 did not induce
up regulation of LGR5 in F3-WT cells, suggesting that LGR5 is
not a direct transcriptional target of Ngn1. LGR5 expression is
also identified in the adult human spinal cord and brain at least at
mRNA levels [39]. At present, the precise physiological function of
LGR5 and downstream signaling pathways remain unknown
owing to the lack of an identified natural ligand. LGR gene
knockout mice showed neonatal lethality due to a breast-feeding
defect caused by ankyloglossia, suggesting an involvement of
LGR5 in craniofacial development [40]. A more recent study
showed that LGR5 deficiency induces premature differentiation of
Paneth cells in the small intestine, accompanied by overactivation
of the Wnt pathway, indicating that LGR5 acts as a negative
regulator of Wnt [41]. A different study revealed that LGR5 is a
marker for the sublineage of intestinal stem cells that are
responsive to Wnt signals derived from stem cell niche [42]. In
the populations of intestinal stem cells, LGR5 labels cycling cells,
while doublecortinlike kinase-1 (DCLK1) marks quiescent cells
[43]. Interestingly, the expression of DCLK2, a putative paralog of
DCLK1, is elevated with a 3.38-fold increase in F3-Ngn1 cells. In
contrast, over expression of DCLK2 in our hENSC was not
recorded.
Correlation with other datasets
In an attempt to confirm the results obtained in the present
study, we correlated the expression profiles of our studies hENSC
with that of adult and fetal human neuroprogenitors available in
public databases such as human hippocampal adult NPCs, human
fetal NPCs from frontal cortex, multipotent adult human
mesenchymal stem cells (hMSCs) as a multipotent adult stem cell
control and adult (differentiated) human hippocampal tissue.
Additional expression data sets in form of excel-files were obtained
from the web. In accordance with the previously studied individual
chips [44], [45], [46], the enrichment encountered in most of
known stem cell markers that had been revealed in the present
study fit well with that observed in their respective progenitor cell
population providing additional validation of our protocol. Similar
to our results, the human brain-derived adult neuroprogenitors
cells (NPCs) showed high expression of the neural stem cell marker
NES (nestin), as well as of OLIG2, MSl1, NKX2-2, and CD44.
NES and MSI1 were already reported in adult NPCs by Hermann
et al [47]. In addition, the expression of various SOX genes was
Figure 4. M phase Pathway. Ninety-one pathways were significantly found in the 1932 down-regulated mRNA set, among them we noted ‘‘M
phase’’ The 1932 down-regulated mRNA set are significantly enriched by mRNA coding for proteins involved in ‘‘M phase’’ pathway.
doi:10.1371/journal.pone.0028420.g004
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(NGFR) genes were as well highly expressed as revealed by both
the gene array as well as on RT-PCR level [47]. The fetal NPCs
showed a high expression, for example, of NES, PROM1
(prominin1, CD133), Olig2, MSI1, as well as SOX genes such
as SOX2, SOX3, SOX4, SOX9, and SOX11. In contrast, human
mesenchymal stem cells (hMSCs) expressed various extracellular
matrix proteins, such as various collagen isoform and other genes
related to connective tissue and its metabolism (LOXL1, LOXL2,
LUM).Fully differentiated neural tissue like the hippocampus
expressed neuronal and glial genes like NTRK2, NTRK3, MBP,
and GFAP [47].
Hierarchical clustering of adult NPCs and tissues containing
mainly white matter, such as spinal cord and corpus callosum, is
characterized by a strong expression of MHCII genes and myelin
components such as peripheral myelin protein two (PMP2),
myelin-associated glycoprotein (MAG), or the myelin-oligoden-
drocyte glycoprotein (MOG) [48]. In the present study, PMP2,
PMP22 and MOG were up-regulated to 10.17, 4.43, and 9.70 fold
respectively in SN neurons while they were not detected in
hENSC. Interestingly, in contrast to the findings of Maisel et al
[48] CD44 and GDF1/LASS1 were not expressed in our hNSCs
samples. Such finding might point to unrestricted stem cell
potential of our examined hENSC line in contrast to adult NPC
where CD44 and GDF1/LASS1 were overexpressed [48].
Our data revealed that genes specific for differentiated neurons
such as SNAP25 was markedly up-regulated to 7.49 fold in SN
samples, while it was not detected in human ENSC. These
findings were in harmony with that of Maisel et al [48] who
demonstrated that a number of genes specific for neurons were
transcribed only on reduced levels in different neuroprogenitors
cells such as the 25-kDa synaptosome-associated protein
(SNAP25), and neurogranin (NRGN).
In the present study, genes specifically expressed in adult NPCs
such as low-affinity nerve growth factor receptor precursor (p75,
NGFR), Nestin (NES), the dual specific phosphatase 10 (DUSP10),
the CCmotif containing chemokine receptor seven (CCR7), the
transcription factor four (TCF4), the G protein-coupled receptor
17 (GPR17), and the chondroitin sulfate proteoglycan four
(CSPG4) were specifically under-expressed in our hNSC line, a
findings conflicted with those of Maisel et al [48] who
demonstrated a distinct over-expression of these genes.
By looking for genes that are specifically overexpressed in our
hENSCs but not in SN samples, we could retrieve a large list
containing genes associated with mitosis (CDC2, MCM2, PCNA,
or CDKN3) or being critical for maintaining an undifferentiated
state, such as SOX2, SOX3, SOX4, and SOX9. This category
also includes the transcription factor eight (TCF8, also named
Zfhep/deltaEF1), which was found to be expressed in early neural
progenitors in the rodent brain [49]. In addition, overexpression of
TCF8 was detected in vascular smooth muscle cells, human
vascular endothelial cells, and in hMSCs, which points to a more
general role for this gene in the development of human stem cells.
In contrast to the finding Maisel et al [48] the MEIS1 gene was
under-expressed in our hENSC line. Like other homeobox genes,
this gene plays a crucial role in normal development. MEIS1 is
especially involved in limb formation [50] but is also important for
leukemic transformation [51]. A dominant-negative MEIS1 splice
variant was reported to yield cell clones with impaired cell
proliferation, gain of differentiated phenotype, increased contact
inhibition, and cell death in human neuroblastoma lines [52]. Our
MEIS1 expression pattern didn’t fit that observation and suggests
a non-significant role for the gene in human neural development.
We did not detect expression of more mature markers (choline
acetyltransferase, tyrosine hydroxylase (TH) or those of late glial
markers (glial fibrillary acidic protein, GFAP), myelin associated
glycoprotein, MAG), oligodendrocyte transmembrane, OSP),
suggesting that the neural cells in the sample were indeed NSC.
Our hENSC samples expressed NSC genes and did not express
mature neuron, oligodendrocyte, GFAP or non-neuronal lineage
genes indicating absence of cell contamination.
In the present study, KEGG pathway analysis of the top 1200
unregulated genes (Log2#5–12) of hENSC showed significant
enrichment for eight molecular pathways: cell cycle, oocyte
meiosis, p53 signaling pathway, progesterone-mediated oocyte
maturation, viral myocarditis, ABC transporters, vibrio cholerae
infection, and homologous recombination. The cell cycle pathway
are dominated with genes regulating cell proliferation and mitosis
such as E2F transcription factor 2, TTK protein kinase, c-abl
oncogene 1, receptor tyrosine kinase, cell division cycle 2, G1 to S
and G2 to M, cyclin A2, cyclin B1, cyclin B2, cyclin-dependent
kinase 2, pituitary tumor-transforming 1; pituitary tumor-trans-
forming 2, protein kinase CHK2-like; and tumor protein p53. In
addition to genes involved in cell proliferation and cell division
regulation, several genes related tumor transformation and tumor
control were also encountered such as pituitary tumor-transform-
ing 1 and pituitary tumor-transforming 2 and tumor protein p53.
The differential expression of these genes is probably result of the
embryonic nature of our examined cell lineage.
Our results could be compared to those of Yoko et al. [53] who
demonstrated that genome-wide analysis of neural progenitor cells
revealed 1,098 annotated mRNAs, the levels of which showed a
statistically significant (P,0.05) $1.2-fold change in Tis21-
GFP+S-phase NPCs as compared with Tis21-GFP – S-phase
NPCs, with 410 mRNAs being up regulated and 688 mRNAs dow
nregulated in Tis21-GFP+cells. Among the 1,098 genes the
functions of which suggested that they may be involved in the
observed cell-cycle phase alterations, notably the 3.3-fold reduc-
tion in S-phase duration (from 8.0 to 2.4 h, Table 1), in Tis21-
GFP+compared with Tis21-GFP – NPCs. Indeed, alterations in
mRNA levels were observed for genes involved in cell-cycle
regulation and DNA replication and repair. Specifically, genes
expected to be associated with a reduction in S-phase duration,
such as the transcription factor E2f1 [54], [55], the phosphatase
Cdc25a [56], cyclin G2 [57] and topoisomerase II alpha [58], showed up
regulated mRNA levels in Tis21-GFP+NPCs. Conversely, genes
expected to be associated with an increase in S-phase duration,
such as the repressor E [59], [60] and the ubiquitin ligase complex
subunit Fbxw7 [61], showed downregulated mRNA levels in
Tis21-GFP + NPCs.
Human substantia nigra was chosen because it contains a subset
of dopaminergic neurons and glial cells in a mixed population and
thus represents a common situation in the laboratory. Examining
gene expression identified markers, such as TH, DDC, and DAT,
in which the magnitude of change was sufficient to be readily
assessed. We concentrated on a list of genes for dopaminergic
neurons based on the published literature, using information about
genes which were differentially expressed at levels that could be
detected by the array. For example, LMX1B, a transcription
factor required for dopaminergic neuronal development was over
expressed by 2.42 fold in a human substantia nigra sample. Luo et
al. [25] demonstrated that although LMX1B was not detected
using a focused array in samples from human substantia nigra, this
gene was detected by RT-PCR. These results indicate the
reasonable sensitivity of Agilent’s microarray to detect key player
genes involved in the process of dopaminergic differentiation.
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(tyrosine hydroxylase, TH) or 2–3 markers for dopaminergic
neurons (e.g. amino acid decarboxylase (AADC), dopamine
transporter (DAT), vesicular monoamine transporter 2 (VMAT2))
have been used to indicate dopaminergic identity of neurons. In
our study, several markers specific for SN samples differentiation
were characterized (Tables 2, 3). Insulin-like growth factor 2
mRNA binding protein 1 was shown to be highly expressed by a
12.17 fold increase in SN samples. Other gene lists that were
highly expressed in our examined samples of human SN include
discs, large (Drosophila) homolog-associated protein 5 (DLGAP5),
cyclin B2 (CCNB2), topoisomerase (DNA) II alpha 170 kDa
(TOP2A), Holliday junction recognition protein (HJURP), sulfo-
transferase family, cytosolic, 6B, member 1 (SULT6B1), collagen,
type II, alpha 1 (COL2A1), asp (abnormal spindle) homolog,
microcephaly associated (Drosophila) (ASPM), aurora kinase B
(AURKB), centromere protein A (CENPA), developmental
pluripotency associated 4 (DPPA4), thymosin beta 15a; thymosin
beta 15B (TMSB15A), maternal embryonic leucine zipper kinase
(MELK), pentraxin-related gene, rapidly induced by IL-1 beta
(PTX3), and centromere protein F, 350/400 ka (mitosin)
(CENPF).
Interestingly, 18 dopamine-related genes over expressed in
mesoncephalic primary culture (MesPC) of DA neurons are
described as involved in cell differentiation; a subgroup of this,
composed of 8 genes, is involved in neuron differentiation. Five
dopamine-related MesPC genes are also associated with neurode-
generative diseases. The dopamine-related genes over-expressed in
Mes. DA neurons better resampled neurophysiologic events, as
they were found associated to synaptic transmission (9 genes),
transmission of nerve impulse (9 genes), and behavior (7 genes)
[62].
Neurogenic basic helix-loop-helix (bHLH) factors Mash1,
neurogenins (Ngns) and NeuroD3 (also known as Ngn1) play
important roles in Nurr1-induced mesoncephalic DA (mDA)
neuronal differentiation [63]. While the role of Ngn2 in the
development of mDA neurons is well known [64], [65], less
information is available concerning Neurogenin [66]. In addition
to inducing neurogenesis by functioning as a transcriptional
activator, COUPTFII (Nr2f2) seems to be involved in tangential
GABAergic interneurons migration in the developing brain,
through the regulation of short- and long-range guidance cues
[67]. Functions of Nr2f2 in the mDA phenotype definition are still
to be described.
Our results show that the analysis of the expression arrays data
using DAVID could reliably distinguish between hENSC and SN
samples. It is important to emphasize that the comparison between
the NSCs and the SN samples that had been conducted in the
present study is not a direct precursor and differentiated cell
comparison. The data presented here compares only stem cells
(NSC) at a single time point in culture, undifferentiated, and a
multicellular tissue from postmortem adult substantia nigra. We
concentrated on the expression profiling of genes that had showed
a wide range of fold increase from 2 to more than 12 folds. These
include signaling molecules for Wnt-Fzd, TGF-b, Notch, fibroblast
growth factor (FGF), and BMP (bone morphogenetic protein)
pathways. By comparison of gene expression profiling in signaling
groups between undifferentiated hENSC cells and substantia nigra
samples, we have noted that some known and required pathways
for induction and formation of dopaminergic neurons were
activated in the SN samples. We observed enhanced expression
of Nr4a2 (3.76 fold increase), En1 (6.41 fold increase), GFRA2
(5.15 fold increase) in the human substantia nigra samples that
have previously been reported as signaling pathways in dopami-
nergic differentiation. At the same time, we could not detect any
significant increase in dopaminergic genes such as Smoh, and Fzds
as previously reported by Luo et al. [68]. Shh-Smoh activation and
FGF8 signaling are known to be key players in midbrain pattering
and genesis of dopaminergic neurons [69], [70]. Nr4a2 is a
transcription factor and is expressed in both dopaminergic
precursors and neurons in ventral midbrain, and deletion of
Nr4a2 results in a loss of dopaminergic neurons in ventral
midbrain [71], [72], [73]. Engrailed genes (En1 and En2) were
shown to be involved in dopaminergic neuron survival and
maintenance [74]. Activation of Wnt-Fzds pathways has multiple
functions, including promoting proliferation of NSCs and
dopaminergic precursors and differentiation from dopaminergic
precursors to their mature neurons depending on the members of
Wnts involved [75], [76], [77].
Although further dissection of signaling pathways involved in
promoting dopaminergic formation is needed, our results suggest
that similar pathways are activated in dopaminergic differentiation
and in midbrain dopaminergic neuron formation during develop-
ment such as cell adhesion molecules (CAMs), (16 genes),
neuroactive ligand-receptor interaction (17 genes), tyrosine
metabolism (6 genes), beta-Alanine metabolism (4 genes), trypto-
phan metabolism (5 genes), and calcium signaling pathway (11
genes). The cell adhesion molecules (CAMs) pathway are
dominated by genes in the cluster up-regulated with dramatic
fold change ranging from 5–12. The genes are involved in
regulation of neuronal pre-and postsynaptic activities as well as
Schwann cells and oligodendrocyte differentiation such as neural
cell adhesion molecule 1, contactin 1, and contactin 2 (axonal),
and claudin 11.
One focus of our study was to characterize a complex series of
signaling programs potentially involved in the priming process of
hNSCs. A better understanding of these signaling pathways at a
cellular level would be of great assistance to the elucidation of the
mechanisms underlying stem cell lineage specification and to the
discovery of potential targets for stem cell therapy, gene therapy
and pharmaceuticals. The signaling molecules changed during
differentiation of hNSC into DA neurons were classified into 11
well-defined pathways, including G-protein signaling, Wnt, Notch,
and TGF-b pathways. Notch signaling pathway has been reported
widely to regulate cell fate determination, cell polarity and
differentiation. Notch pathway components were regulated
differently. For example, the transcription factor enhancer of split
and the ligand deltex, and TACE were down regulated while
CBF1 interacting corepressor was up- regulated by 2.02 fold in our
hENSC samples. Notch signaling pathway has been reported
widely to regulate cell fate determination, cell polarity and
differentiation [55]. Notch pathway components were regulated
differently. For example, the transcription factor enhancer of split
and the ligand deltex, and TACE were down regulated while
CBF1 interacting corepressor were up-regulated by 2.02 fold in
our hENSC samples. It is believed that the Notch pathway inhibits
a specific pathway of differentiation and induces differentiation
along alternative pathways and that the Notch pathway is involved
in asymmetric cell division and cell polarity [56]. The Wnt
signaling pathway has been reported to be involved in extensive
biological processes such as animal development, oncogenesis, and
cell polarity establishment and so on [57]. It is widely believed that
activation of the Wnt signaling pathway induces self-renewal of
stem cells, and Wnt proteins act as cell growth factors [58]. Beta-
catenin interacting protein one (CTNNBIP1) negatively regulates
the Wnt pathway by inhibiting the interaction of beta-catenin with
Tcf4 and repressing beta-catenin-Tcf4-mediated transactivation
[59]. The expression level of Drctnnb1a (down-regulated by
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beta-catenin expression [60]. From our data, the expression of
CBF1 was increased while the transcription factor enhancer of
split and the ligand deltex, and TACE were down regulated in
hNSC, suggesting that the Wnt signaling pathway was inhibited
and that hNSCs could then gain the ability to exit the cell cycle
and differentiate into neuronal cells.
In the present study, in contrast to those reported by Jun-ichi
Satoh et al [36] several Wnt target genes, such as FGF [61] and
Dick homolog 1 (DKK1)[43], and MMP9 [62] are coordinately
down regulated, in our hENSC. FGF9 inhibits astrocyte differen-
tiation of adult mouse NPC [63]. DKK1 is a negative regulator of
Wnt signaling in HB1.F3 cells [64] MMP9 plays a central role in
migration of adult NSC and NPC [65]. Moreover, Ngn1 which is
also identified as a target of Wnt signaling, and it inhibits the self-
renewal capacity of mouse cortical neural precursor cells [66] is not
up-regulated in our hENSC. The expression of LGR5 is also
controlled by the sonic hedgehog (SHH) signaling pathway [67].
SHH promotes Ngn1 expression in trigeminal neural crest cells
[68]. Interestingly, both Wnt and SHH signaling pathways which
are know to play a central role in NSC development and
differentiation [69] were not up-regulated in our hENSC.. The
down-regulation of Ngn1, and LGR5 in our examined hENSC
indicate that both Wnt and SHH signaling pathways cells were not
crucial for the process of proliferation, and differentiation of our
examined line of hENSC. Although it remains to be investigated
whetheraspecializedsubsetofLGR5NSCexistsinvivointheadult
human central nervous system (CNS).
Our data could be compared with those of Greco et al [61] who
demonstrated that five functional categories were dominating
among the 268 genes over-expressed in mesencephalon primary
culture which are rich in DA: developmental process (95 genes),
lipid metabolic process (34 genes), mitochondrion (29 genes),
extracellular matrix (22 genes), and lysosome (15 genes).
Additionally, neurogenesis (16 genes) and neuron differentiation
(14 genes) were also significantly over-represented. Interestingly,
10 genes coding for collagens were among this group of genes with
high fold change. Gene ontology (GO) classification showed
significant over-representation of such families as neuron differ-
entiation (34 genes), neurogenesis (37 genes), and neuron
development (26 genes), suggesting a central role of EGR1-SP1
module during production of DA neurons.
In a recent studies, Caiazzo et al [78], and Qiang et al [79]
identified a minimal set of three transcription factors—Mash1 (also
known as Ascl1), Nurr1 (also known as Nr4a2)a n dLmx1a—that are
able to generate directly functional dopaminergic neurons from
mouse and human fibroblasts without reverting to a progenitor cell
stage.Ourresultsareconsistentwiththoseof Caiazzo et al[78], and
Qiang et al [79] where Nurr1 and Lmx1a were up-regulated by 3.76,
and 2.42 fold respectively in SN samples which is rich in DA. In
contrast,up-regulationofMash1(alsoknownasAscl1)wasnot detected.
Conclusion
Neural stem cells (NSC) with self-renewal and multipotent
properties serve as a promising cell source for transplantation to
treat neurodegenerative insults such as Parkinson’s disease. To
efficiently induceneuronal lineage cells from NSCfordopaminergic
neuron (DA) replacement therapy, we should clarify the intrinsic
genetic programs involved in regulation of human NSC differen-
tiation. We used Agilent’s and Illumina’s Whole Human Genome
Oligonucleotide Microarray to monitor at least 41000 genes. We
identified 1830 up-regulated and 1932 down-regulated mRNA in
SN vs hE_NSC. Careful analysis of the resulting data using DAVID
has permitted us to distinguish several genes and pathways between
the two examined groups. We found that the set of genes expressed
more highly in hENSC is enriched in molecules known or predicted
to be involved in M phase of the mitotic cell cycle. On the other
hand, the genes enriched at SN samples include a different set of
functional categories, namely dopamine neurotransmitter release
cycle, synaptic transmission, central nervous system development,
structural constituents of the myelin sheath, internode region of
axon, myelination, cell projection, cell soma, myelin sheath, ion
transport, and the voltage-gated ion channel complex. As the SN
tissue is known to be rich in DA neurons, the present results might
provide insights to identify the key regulators and biomarkers that
may allow targeted selection of a limited number of genes or
transcription factors to be used for direct reprogramming of NSC
into DA cells with an ultimate goal of obtaining different types of
allogenic neurons including personalized DA neurons.
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